Study Start Up and Regulatory Affairs Specialist (2 years plus experience)

Oncology Voice Network LLC; Northern (KY); Hybrid; USD 85,000 - 120,000; Full time

Job summary

Ergomed is seeking a Specialist, Study Start Up and Regulatory Affairs to coordinate site initiation readiness and ensure regulatory compliance across multiple countries. You will serve as a key liaison between internal teams, clients, and external stakeholders, delivering regulatory milestones within defined timelines.

The role requires a graduate degree in a life sciences field and at least two years in pharma/CRO, with strong knowledge of ICH GCP and country-specific SSU requirements across

Qualifications

• Graduate degree in Chemistry or Life Sciences, Nursing, or equivalent.
• Minimum 2 years in pharmaceutical/CRO or regulatory bodies.
• Strong knowledge of ICH GCP and national regulations.
• Experience with SSU/Regulatory delivery across Europe and the Americas.

Responsibilities

• Lead study start-up and regulatory activities for assigned countries or projects.
• Prepare, review, and quality-control regulatory documents and submissions.
• Draft and negotiate clinical site and ancillary agreements as needed.
• Identify risks to timelines and implement corrective actions.
• Act as liaison between internal teams, clients, and external stakeholders.

Skills

Regulatory affairs

SSU planning

Cross-functional collaboration

Attention to detail

Education

Bachelor's degree in Chemistry / Life Sciences / Nursing

Job description

## Job DescriptionCompany Description Medicine moves forward here. So will you. Ergomed is a specialist clinical research organization focused on rare disease and select oncology indications. We focus on the most complex trials, the studies where experience, judgement, and rigorous operational accountability make the biggest difference. We partner with small to midsize biotech companies to move promising therapies through early phase development, so they reach the patients sooner. We choose complex work on purpose. Rare disease and oncology trials carry real operational risk, and our people are experts at reducing it, protecting timelines, data quality and the experience of sites and patients at the same time. It is demanding, meaningful work, and no one here forgets that patients cannot wait. That is why culture matters to us as much as capability. We have built a collaborative, international team where people share ideas, grow their careers and are trusted to take ownership early. With colleagues across North America, South America, Europe, Asia and Australia, we value teamwork, flexibility and a real commitment to work-life balance, because good science comes from people who feel supported. If you want work with purpose, the agility to make an impact and a team that cares about the people behind the work as much as the work itself, we would love to hear from you. Job Description The Specialist, Study Start Up and Regulatory Affairs leads and coordinates all activities related to achieving site initiation readiness. The role provides subject matter expertise, ensures regulatory compliance, and serves as a key liaison between internal teams, clients, and external stakeholders • Accountable for delivery of assigned study start-up and regulatory milestones within defined scope. • Make independent decisions within assigned scope regarding regulatory processes and documentation approaches. • Handles medium-complexity regulatory environments, including multi-country requirements where applicable. • Leads study start-up and regulatory activities for assigned countries or projects of medium complexity, ensuring delivery in line with timelines, quality standards, and regulatory requirements. • Leads preparation, review, and quality control of regulatory and study start-up documentation (including submissions, essential documents, and translations) to ensure completeness, accuracy, and compliance with ICH-GCP and country-specific requirements. • Responsible for drafting, negotiating, finalizing, and executing clinical site agreements, ancillary agreements as well as amendments at country or regional level, in accordance with project requirements and country regulations and within the projected delivery timelines • Review all relevant documentation e.g. labels, patient information sheets, diary cards, insurance etc, to ensure compliance with ICH GCP & country specific requirements. • Contribute towards the preparation and/or review of complex technical/scientific/legal documentation. • Arrange for and/or review translation of essential documents as required • Provide regulatory/SSU strategic input to internal and external customers. Develop the regulatory strategy and the SSU Plan, joint operating procedures and core documents • Promptly identify and escalate risk/potential risk to the project team which may jeopardise deliverables; support corrective/preventive actions • Performs other work-related duties as assigned. Qualifications • Graduate degree in Chemistry or Life Sciences, Nursing or equivalent combination of education and experience • Minimum 2 years within pharmaceutical or CRO industry or Regulatory body • Good knowledge of ICH GCP and national regulations for territories of competency • Good understanding of specific country requirements pertaining to SSU/Regulatory delivery in multiple countries within Europe and/or the Americas Additional Information When you join Ergomed Group, you make a difference by helping to bring safe and effective pharmaceutical treatment to patients around the world. You’ll join a passionate and collaborative team of experts in clinical research, pharmacovigilance, and quality consulting. We are diverse in many ways, yet our values unite us. Our values are how we work, not words on a wall. If they sound like you, you will feel at home here. • Quality: we hold ourselves to the standard patients deserve. • Integrity and trust: we do the right thing, especially when it is hard. • Drive and passion: we care about the outcome, because someone is waiting on it. • Agility and responsiveness: we move quickly, because patients cannot wait. • Belonging: everyone is welcome, and every voice counts. • Collaborative partnerships: we go further by going together. We look forward to welcoming your application.